MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic hepatitis C virus (HCV) in Canada MAVIRET received approval through Health Canada’s… Read More
Toronto, ON – LifeLabs, Canada’s leading provider of laboratory diagnostics, has been voted by Canadians as the Most Trusted Brand in Health Diagnostic Services for the fourth consecutive year, earning the prestigious 2026 BrandSpark Most… Read More
Preliminary findings indicate that key sex differences in diabetic retinopathy disease presentation could be essential for precision diagnostics. Sex differences could play a key role in diagnosing diabetic retinopathy, according… Read More
RANKLIN LAKES, NJ – BD, a leading global medical technology company, announced a significant milestone in its advanced tissue regeneration strategy: the first Phasix™ Mesh laparotomy reinforcement case performed in… Read More
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to… Read More
